Technology Assessment and Cost-Effectiveness Analysis: Misguided Guidelines?
Naylor, C. David
Williams, J. Ivan
Canadian Medical Association Journal. 1993 Mar; 148(6): 921-924.
Biomedical Technologies; Costs and Benefits; Decision Making; Economics; Ethicists; Evaluation; Guidelines; Health; Health Care; Justice; Life; Methods; Public Participation; Public Policy; Quality of Life; Research; Resource Allocation; Standards; Technology; Technology Assessment; Therapeutic Research; Utilitarianism;
Showing items related by title, author, creator and subject.
Incorporating Future Costs in Medical Cost-Effectiveness Analysis: Implications for the Cost-Effectiveness of the Treatment of Hypertension Johannesson, Magnus; Meltzer, David; O'Conor, Richard M. (1997-10)
Placing Patients in the Queue for Coronary Revascularization: Evidence for Practice Variations From an Expert Panel Process Naylor, C. David; Basinski, Antoni; Baigrie, Ronald S.; Goldman, Bernard S.; Lomas, Jonathan (1990-10)A panel of 16 cardiologists and cardiac surgeons rated 438 case scenarios for the maximum acceptable delay prior to revascularization, using a scale with seven interventional time frames and two nodes for designating dubious ...